sodium-morrhuate and Arteriovenous-Malformations

Large craniofacial venous malformations frequently cause significant cosmetic and functional problems. Treatment of the lesions early in life helps to avoid these problems. We present a case of a large cervicofacial venous malformation.. The patient was treated with a 5% benzyl alcohol solution of sodium morrhuate. The treatment was begun when the patient was 3 months of age, with a total of 23 injections.. The lesion had completely disappeared by age 10. No major complications were observed except a superficial tissue loss on the temporal region. It was healed by conservative treatment. There were no recurrences during the 14-year follow-up.. It is difficult to conclude that this type of treatment is the best choice for patients with venous malformation on the basis of a single case. However, intralesional sclerotherapy should be kept in mind as a saving treatment option in cases of large venous malformations in anatomic regions that present challenges to both the surgeon and the patient. Intralesional sclerotherapy can be performed without serious complications if the sclerosing agent is selected and injected cautiously.

Topics: Arteriovenous Malformations; Craniofacial Abnormalities; Face; Female; Follow-Up Studies; Humans; Infant, Newborn; Sclerosing Solutions; Sclerotherapy; Sodium Morrhuate; Treatment Outcome; Veins

To evaluate the value of embolization on arteriovenous malformations (AVM) in the oral and maxillofacial region and to investigate the efficacy of several different embolic materials.. 10 cases with AVMs, including 5 AVMs mainly in the soft tissue and 5 intraosseous lesions, were embolized. Clinical and angiographic effects were analyzed during the 3 to 16 months follow-up.. In the 5 cases embolized without other treatment, 1 case was embolized 3 times, 3 cases twice, and 1 case once. In these cases, postembolization angiograms revealed complete or nearly complete disappearance of the lesions. In the other 5 cases, embolized before surgery, intraoperative bleeding was significantly decreased. All these patients were free of recurrence during follow-up. Among the materials employed, NBCA seemed to offer a better result.. Embolization may serve as the primary therapy for some AVMs in the oral and maxillofacial region, or as a routine preoperative adjunct for patients with severe intraosseous or disfiguring AVMs.

Topics: Adolescent; Adult; Alveolar Process; Angiography; Arteriovenous Malformations; Blood Loss, Surgical; Child; Child, Preschool; Embolization, Therapeutic; Enbucrilate; Face; Female; Follow-Up Studies; Humans; Jaw Diseases; Lip Diseases; Male; Mouth Diseases; Polyvinyl Alcohol; Preoperative Care; Sclerosing Solutions; Sodium Morrhuate; Steel; Tissue Adhesives

Topics: Angiography, Digital Subtraction; Arteriovenous Malformations; Embolization, Therapeutic; Facial Neoplasms; Hemangioma; Humans; Maxillary Neoplasms; Sodium Morrhuate